To paraphrase the the Rajun Cajun -James Carville- “it’s all about the deal stupid”. We can wax lyrically about full enrolment, tox studies & the science - but unless there is an advantageous commercial arrangement which isn’t pulling our pants down - the science in itself won’t get us to what the retail SH wants & close to the SP of the quoted pie in the sky estimates. Our ultimate SP will be detirmined by “ the deal” & commercial reality will prevail.
What is the BOD goal / ambition in light of their background? SH wealth & interests should be paramount given their directorial obligations. However my concern is that their scientific & medical egos may prevailand that they will simply be satisfied getting a product closer to market. That may satisfy the big end of town & shorter tenured shareholders - AEF / Belinda but what about the long tenured ones. Thoughts : comments ?
To paraphrase the the Rajun Cajun -James Carville- “it’s all...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
0.001(1.35%) |
Mkt cap ! $67.61M | |||
| Open | High | Low | Value | Volume |
| 7.4¢ | 7.5¢ | 7.3¢ | $25.98K | 350.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15553 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 146315 | 2 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.5¢ |
Change
0.001 ( 1.35 %) |
||||
| Open | High | Low | Volume | ||
| 7.3¢ | 7.5¢ | 7.3¢ | 48397 | ||
| Last updated 15.37pm 17/05/2024 ? | |||||
| PER (ASX) Chart |